Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Dess

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
European Urology|December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate CancerNeil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
JAMA Oncology|March 28, 2020
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate CancerRobert T Dess, Yilun Sun, William C Jackson, et al.
European Urology|April 26, 2022
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP ConsortiumAmar U Kishan, Xiaoyan Wang, Yilun Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate CancerDaniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
JAMA Oncology|October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the ProstateRobert T Dess, Krithika Suresh, Michael J Zelefsky, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium AnalysisSagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
JAMA Oncology|November 20, 2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-AnalysisNicholas G Zaorsky, Yilun Sun, Abdenour Nabid, et al.
European Urology|May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate CancerRebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
European Urology|December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate CancerNeil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
JAMA Oncology|March 28, 2020
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate CancerRobert T Dess, Yilun Sun, William C Jackson, et al.
European Urology|April 26, 2022
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP ConsortiumAmar U Kishan, Xiaoyan Wang, Yilun Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate CancerDaniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
JAMA Oncology|October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the ProstateRobert T Dess, Krithika Suresh, Michael J Zelefsky, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium AnalysisSagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
JAMA Oncology|November 20, 2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-AnalysisNicholas G Zaorsky, Yilun Sun, Abdenour Nabid, et al.
European Urology|May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate CancerRebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
Pageof 10